Bruce L A Carter's Net Worth

$12 Million

Estimate Recalculated Sep 8, 2024 07:23PM EST

Who is Bruce L A Carter?

Bruce L A Carter has an estimated net worth of $12 Million. This is based on reported shares across multiple companies, which include ENANTA PHARMACEUTICALS INC, ZYMOGENETICS INC, RENOVIS INC, Mirati Therapeutics, Inc., Xencor Inc, QLT INC/BC, ALSP Orchid Acquisition Corp I, and Regulus Therapeutics Inc..

SEC CIK

Bruce L A Carter's CIK is 0001225503

Past Insider Trading and Trends

2019 was Bruce L A Carter's most active year for acquiring shares with 9 total transactions. Bruce L A Carter's most active month to acquire stocks was the month of December. 2019 was Bruce L A Carter's most active year for disposing of shares, totalling 16 transactions. Bruce L A Carter's most active month to dispose stocks was the month of July. 2010 saw Bruce L A Carter paying a total of $1,183,300.20 for 457,500 shares, this is the most they've acquired in one year. In 2010 Bruce L A Carter cashed out on 894,750 shares for a total of $4,570,312.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ENANTA PHARMACEUTICALS INC (ENTA) Snapshot price: $11.54

Investor

Bruce L A Carter used to own units in Common Stock but no longer holds any shares there. From 2022 to 2024 Bruce L A Carter acquired a total of 15,280 shares in ENANTA PHARMACEUTICALS INC at a cost of $370,632.00, Bruce also disposed a total of 15,280 shares of ENANTA PHARMACEUTICALS INC equalling to $1,256,373.24.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 6
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
$46.71
-$253,490.05
0
Scheduled
Mar 21
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Feb 26
Form 4
—
0
$61.28
-$117,124.96
0
Scheduled
Mar 11
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
$56.71
-$515,126.23
0
Scheduled
Feb 11 - Feb 12
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Feb 11
Form 4
—
0
—
—
0
Feb 19
Form 4
—
0
—
—
0
Nov 22
Form 3
—
0
—
—
0
No matching records found

ZYMOGENETICS INC No price found

CEO & Chairman the Board

Bruce L A Carter owns 115,399 units of Common Stock.acquired a total of 602,850 shares in ZYMOGENETICS INC at a cost of $1,898,378.88, Bruce also disposed a total of 642,951 shares of ZYMOGENETICS INC equalling to $7,917,226.66.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-80.24%
-468.75K
$9.75
-$4,570,312.50
115.4K
Oct 8
Form 4
+269.37%
426K
$2.78
$1,183,300.20
584.15K
Aug 19
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Sep 16
Form 4
—
0
—
—
0
Jun 10
Form 4
+7.48%
11K
$9.13
$100,461.90
158.15K
Feb 19
Form 4
—
0
—
—
0
Jan 18
Form 4
+0.07%
100
—
—
147.15K
Jan 18
Form 4
+12.00%
15.75K
$12.56
$197,846.78
147.05K
Aug 3
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
$11.41
-$431,557.50
131.3K
Aug 24
Form 4
—
0
$12.27
-$474,307.50
131.3K
Mar 13
Form 4
—
0
$11.35
-$428,500.00
131.3K
Jan 9
Form 4
—
0
$10.39
-$380,557.50
131.3K
Jan 5
Form 4
—
0
$10.39
-$380,557.50
131.3K
May 17
Form 4
—
0
$11.17
-$419,375.00
131.3K
Feb 14
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Jan 26
Form 4
-15.56%
-24.20K
$17.16
-$415,289.16
131.3K
Jun 21
Form 4
—
0
—
—
0
Jan 7
No matching records found

RENOVIS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jan 16
Form 3
—
0
—
—
0
No matching records found

Mirati Therapeutics, Inc. (MRTX) No price found

Investor

Bruce L A Carter used to own units in Common Stock but no longer holds any shares there. From 2016 to 2024 Bruce L A Carter acquired a total of 52,273 shares in Mirati Therapeutics, Inc. at a cost of $839,470.00, Bruce also disposed a total of 52,273 shares of Mirati Therapeutics, Inc. equalling to $3,947,876.90.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-17.27K
—
—
0
Jan 23
Form 4
+65.05%
6.81K
$58.75
$399,970.00
17.27K
Dec 29
Form 4
+73.81%
4.44K
—
—
10.46K
Jan 20
Form 4
—
0
$56.25
-$584,899.09
6.02K
Aug 12
Form 4
+73.27%
2.55K
—
—
6.02K
Jan 14
Form 4
—
0
$91.95
-$383,251.98
3.48K
Scheduled
Apr 5
Form 4
—
0
$98.95
-$414,762.59
3.48K
Scheduled
Feb 2
Form 4
+73.75%
1.48K
—
—
3.48K
Jan 15
Form 4
—
0
$126.53
-$538,871.63
2K
Scheduled
Dec 14
Form 4
—
0
$66.60
-$269,173.49
2K
Scheduled
Aug 11
Form 4
—
0
$56.82
-$400,320.40
2K
May 18
Form 4
∞
2K
—
—
2K
Jan 3
Form 4
—
0
$50.76
-$263,880.00
0
Scheduled
Nov 20
Form 4
—
0
$48.01
-$247,380.00
0
Scheduled
Aug 21
Form 4
—
0
$40.99
-$205,256.70
0
Scheduled
May 22
Form 4
—
0
$40.21
-$200,581.02
0
Scheduled
Feb 20
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Sep 27
Form 3
—
0
—
—
0
No matching records found

Xencor Inc (XNCR) Snapshot price: $16.18

Investor

Bruce L A Carter owns 48,578 units of Common Stock which is worth $785,992.04. In the year 2013 Bruce L A Carter acquired a total of 96,744 shares in Xencor Inc at a cost of $57,078.96, Bruce also disposed a total of 48,166 shares of Xencor Inc equalling to $1,008,690.25.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-29.16%
-20.00K
$20.61
-$412,237.53
48.58K
Jun 14
Form 4
-3.34%
-2.37K
$22.00
-$52,052.00
68.58K
Jun 2
Form 4
+974.91%
64.34K
$11.39
-$229,933.73
70.94K
May 24 - May 26
Form 4
∞
6.6K
$11.63
-$71,174.03
6.6K
Aug 11 - Aug 15
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
$9.90
-$186,214.00
0
Jun 15
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 12
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found